March 8, 2000Vintage Pharmaceuticals, Inc.
Recalls Levothyroxine Sodium
Charlotte, NC (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Vintage Pharmaceuticals, Inc. is recalling
certain Levothyroxine Sodium, USP, 25 mcg (0.025 mg) tablets, in 100 and 1,000 unit
bottles because of subpotency prior to labeled expiration date.
According to the FDA, over 6,013
1000-tablet bottles and 6,455 100-tablet bottles were distributed in Alabama.
The recalled prescription, used as a
replacement or supplemental therapy in patients with hypothyroidism and as a pituitary TSH
suppressant in the treatment or prevention of various types of euthyroid goiters bears the
Lot Numbers: 024107C, 113038A, 113038D, 071128A, 071128B, 071128C or 071128D.
This ongoing Class II recall
was initiated by Vintage Pharmaceuticals, Inc., by letter dated August 3, 1999. This
is the first public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-222-0
Notice of this product warning was
sent via email to SafeMail
subscribers March 8, 2000.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.